Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
McKesson
Johnson and Johnson
Federal Trade Commission
Baxter
Fish and Richardson
Deloitte
Dow
Medtronic

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,496,553

« Back to Dashboard

Summary for Patent: 4,496,553
Title: Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
Abstract:A pharmaceutical composition containing as active ingredient 5-aminosalicyclic acid or a pharmaceutically acceptable salt or ester thereof allow the treatment of colitis ulcerosa or Crohn's disease by oral administration. A particular slow-release tablet formation and its preparation is disclosed.
Inventor(s): Halskov; Soren (Helsinge, DK)
Assignee: Farmaceutisk Laboratorium Ferring A/S (Vanlose, DK)
Application Number:06/555,533
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,496,553
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 4,496,553

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,496,553

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark1202/80Mar 20, 1980

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Citi
Express Scripts
QuintilesIMS
Accenture
Teva
Daiichi Sankyo
Queensland Health
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.